Gum Care Follow-up and Blood Sugar in Adults With Type 2 Diabetes
Tests reminder texts about gum follow-up in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Periodontal Follow-up and Glycemy in Patients With Type 2 Diabetes
Key facts
- Where
- Ivry-sur-Seine, Lille, Lyon, Nantes, Rennes, Saint-Victor-de-Cessieu, Strasbourg, and Toulouse, FranceSee the 8 sites
Where in France
- Hôpital Charles FoixIvry-sur-Seine, FranceNo longer taking part
- Centre Hospitalo-Universitaire de LilleLille, FranceNo longer taking part
- Hospices Civils de Lyon, Centre de Soins Dentaires.Lyon, FranceNo longer taking part
- Centre Hospitalo-Universitaire de NantesNantes, FranceNo longer taking part
- Centre Hospitalo-Universitaire de RennesRennes, FranceNo longer taking part
- Cabinet libéralSaint-Victor-de-Cessieu, FranceNo longer taking part
- Hopitaux Universitaires de StrasbourgStrasbourg, FranceNo longer taking part
- Centre Hospitalo-Universitaire de ToulouseToulouse, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Hospices Civils de Lyon
- Trial code
- NCT07165171
- Record updated
- 10 September 2025
- Original description
Diabetes is a disease in which the majority of these patients have type 2 diabetes, linked to poor use of insulin by the body.Read full original descriptionShow less
Glycemy After Periodontal Treatment in Patients With Type 2 Diabetes: a Randomized Controlled Trial Comparing Innovative Versus Standard Periodontal Follow-up
Diabetes is a disease in which the majority of these patients have type 2 diabetes, linked to poor use of insulin by the body.
Periodontitis is a chronic disease characterized by an immuno-inflammatory reaction with local production of inflammatory mediators (IL6, TNF-alpha, etc.) and contributes to the increase in the systemic inflammatory load with increased levels of C-reactive protein.
Periodontitis is frequently found in diabetic patients; it is considered a complication of diabetes. Poor glycemic control in diabetes is associated with poor periodontal health, while periodontal infection is associated with dysglycemia and increased insulin resistance.
Periodontal treatment has been shown to reduce HbA1C levels and thus the risk of complications in diabetic patients.
The main objective is to evaluate the impact of innovative periodontal monitoring (with reminder systems and reinforcement of advice by SMS) versus standard periodontal monitoring on the glycemic control of diabetic patients treated for periodontitis, 2 years after the start of periodontal monitoring.
Inclusion: -- Adult aged 18 years or older; Presenting with type 2 diabetes (under ALD), balanced or not, for 6 months or more; Having been treated in the previous 6 months for periodontitis (stages 1 to 4 according to the new classification of periodontal and peri-implant diseases EFP-AAP 2018) in one of the participating centers and presenting a clinical situation allowing the transition to the periodontal follow-up phase (; (absence or limited number of sites presenting clinical signs of persistent periodontal inflammation); Presenting more than 6 teeth; Possessing a smartphone or tablet with internet access; Affiliated to social security; Patient able to read, write and understand French; Having signed a consent to participate in the study.
Exclusion: Patient presenting uncontrolled systemic diseases and diagnosed for less than 6 months or presenting a major aggravation of a systemic pathology according to the judgment of the investigator; Pregnant or breastfeeding women; Persons deprived of liberty by a judicial or administrative decision; Adults subject to a legal protection measure (guardianship, curatorship).